Probiotics, gut microbiota and health.
暂无分享,去创建一个
[1] J. Olsson,et al. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans , 2010, Antonie van Leeuwenhoek.
[2] M. Butel,et al. Gnotobiotic Mouse Immune Response Induced by Bifidobacterium sp. Strains Isolated from Infants , 2007, Applied and Environmental Microbiology.
[3] D. Serban. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. , 2014, Cancer letters.
[4] M. Goldacre,et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies , 2008, Diabetologia.
[5] E. Zoetendal,et al. Isolation of Bifidobacteria from Breast Milk and Assessment of the Bifidobacterial Population by PCR-Denaturing Gradient Gel Electrophoresis and Quantitative Real-Time PCR , 2008, Applied and Environmental Microbiology.
[6] S. Cucchiara,et al. Dominant genotypes in mucosa‐associated Escherichia coli strains from pediatric patients with inflammatory bowel disease , 2009, Inflammatory bowel diseases.
[7] J. Bach,et al. The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update , 2010, Clinical and experimental immunology.
[8] G. Guyatt,et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. , 2013, The Cochrane database of systematic reviews.
[9] Maija Saxelin,et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Haroun Shah,et al. Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Xin Wang,et al. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. , 2013, Diagnostic microbiology and infectious disease.
[12] L. Houghton,et al. Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome. , 2012, Expert review of gastroenterology & hepatology.
[13] H. Wichmann,et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life , 2004, Archives of Disease in Childhood.
[14] S. Roos,et al. Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum , 2009, Journal of applied microbiology.
[15] M. Camilleri. Peripheral mechanisms in irritable bowel syndrome. , 2012, The New England journal of medicine.
[16] J. Cannon,et al. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[17] Willem M. de Vos,et al. Genomics: A gut prediction , 2013, Nature.
[18] M. Butel,et al. Microbiota and Allergy: From Dysbiosis to Probiotics , 2012 .
[19] Rafael Perera,et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome , 2009, BMC gastroenterology.
[20] K. Alfaleh,et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants. , 2014, The Cochrane database of systematic reviews.
[21] Dominique Turck,et al. Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition , 2011, Journal of pediatric gastroenterology and nutrition.
[22] O. Ruuskanen,et al. The hygiene hypothesis of atopic disease--an extended version. , 2004, Journal of pediatric gastroenterology and nutrition.
[23] M. Lomer,et al. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. , 2012, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[24] C. la Vecchia,et al. Probiotics Supplementation During Pregnancy or Infancy for the Prevention of Atopic Dermatitis: A Meta-analysis , 2012, Epidemiology.
[25] C. Dupont,et al. Mise en place de la flore intestinale du nouveau-né , 2007 .
[26] J. Maldonado,et al. Human Milk Probiotic Lactobacillus fermentum CECT5716 Reduces the Incidence of Gastrointestinal and Upper Respiratory Tract Infections in Infants , 2012, Journal of pediatric gastroenterology and nutrition.
[27] H. Szajewska,et al. Meta‐analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare‐associated diarrhoea in children , 2011, Alimentary pharmacology & therapeutics.
[28] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[29] O. Ozdemir,et al. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data , 2010, Clinical and experimental immunology.
[30] L. Dieleman,et al. Probiotics in the Treatment of Human Inflammatory Bowel Diseases: Update 2011 , 2011, Journal of clinical gastroenterology.
[31] Anne Salonen,et al. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. , 2010, Microbiology.
[32] Pooneh Salari,et al. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. , 2012, Inflammation & allergy drug targets.
[33] Susanne Hempel,et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.
[34] B. Björkstén,et al. Safety of D(-)-Lactic Acid Producing Bacteria in the Human Infant , 2005, Journal of pediatric gastroenterology and nutrition.
[35] Gian Franco Gensini,et al. Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report , 2012, Gut.
[36] H. Szajewska,et al. Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment , 2010, Alimentary pharmacology & therapeutics.
[37] D. Gevers,et al. Horizontal transfer of tet(M) and erm(B) resistance plasmids from food strains of Lactobacillus plantarum to Enterococcus faecalis JH2-2 in the gastrointestinal tract of gnotobiotic rats. , 2007, FEMS microbiology ecology.
[38] D. Mack. Probiotics in Inflammatory Bowel Diseases and Associated Conditions , 2011, Nutrients.
[39] S. Mazmanian,et al. The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.
[40] C. Zera,et al. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study , 2012, Archives of Disease in Childhood.
[41] M. Tang,et al. Probiotic use in clinical practice: what are the risks? , 2006, The American journal of clinical nutrition.
[42] S. Nikfar,et al. A Meta-Analysis on the Efficacy of Probiotics for Maintenance of Remission and Prevention of Clinical and Endoscopic Relapse in Crohn’s Disease , 2008, Digestive Diseases and Sciences.
[43] H. Abriouel,et al. Enterococci as probiotics and their implications in food safety. , 2011, International journal of food microbiology.
[44] J. Jacquemin,et al. Possible Role of Catheters in Saccharomyces boulardii Fungemia , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[45] A. Armstrong,et al. Effect of Nutrient Supplementation on Atopic Dermatitis in Children , 2012 .
[46] T. Lherm,et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients , 2002, Intensive Care Medicine.
[47] Liping Zhao,et al. The gut microbiota, obesity and insulin resistance. , 2013, Molecular aspects of medicine.
[48] J. Leonardi-Bee,et al. Probiotics for treating eczema. , 2008, The Cochrane database of systematic reviews.
[49] F. Doucet-Populaire,et al. Tetracycline Resistance Mediated by tet(W), tet(M), and tet(O) Genes of Bifidobacterium Isolates from Humans , 2007, Applied and Environmental Microbiology.
[50] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[51] J. Doré,et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.
[52] Stefano Guandalini,et al. Recommendations for probiotic use-2011 update. , 2011, Journal of clinical gastroenterology.
[53] A. Akobeng,et al. Probiotics for induction of remission in Crohn's disease. , 2008, The Cochrane database of systematic reviews.
[54] D. Snydman. The safety of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] A. Marini,et al. Allergic manifestations in very low‐birthweight infants: a 6‐year follow‐up , 2003, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[56] P. Moayyedi,et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.
[57] S. Patole,et al. Evidence-based guidelines for use of probiotics in preterm neonates , 2011, BMC medicine.
[58] M. Kalliomäki,et al. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years , 2010, International Journal of Obesity.
[59] S. Allen,et al. Probiotics for treating acute infectious diarrhoea , 2010, The Cochrane database of systematic reviews.
[60] Y. Sanz,et al. Understanding the role of gut microbes and probiotics in obesity: how far are we? , 2013, Pharmacological research.
[61] Taixiang Wu,et al. Probiotics for preventing acute upper respiratory tract infections , 2015, The Cochrane database of systematic reviews.